EMM Journal Submission Guide 2026
EMM submission guide: mechanism-only papers without clinical-translation pathway extend revision rounds.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How to approach Experimental and Molecular Medicine
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Define disease relevance |
2. Package | Clarify mechanistic contribution |
3. Cover letter | State translational significance |
4. Final check | Position against translational comparators |
- Quick answer: If you need EMM journal submission clarity today, compare your manuscript's scope with EMM's recent issues and only proceed if your work fits Experimental and Molecular Medicine's experimental medicine or molecular biology focus with credible translational potential.
Run an Experimental And Molecular Medicine pre-submission readiness check before clicking submit, or work through this guide manually.
Editorial detail (for desk-screen calibration). Experimental & Molecular Medicine is the official journal of the Korean Society for Biochemistry and Molecular Biology (KSBMB), published in partnership with Springer Nature. Submissions route through Editorial Manager (the same system used across most Springer Nature titles); the journal's author-facing pages live under nature.com/emm but the submission intake is the standard Springer Nature Editorial Manager flow. Allow 45 to 60 minutes for first-time submission if all materials are ready. The package must clear: 200-word structured abstract, 6,000-word main-text cap, explicit data and code availability statements (deposition in recognized repositories required at submission, not "available on request"), molecular-mechanism block matched to a translational implication, and ORCID for the corresponding author. Across our pre-submission reviews of EMM manuscripts, the editorial triage pattern is shaped by the dual mission of KSBMB and Springer Nature: the journal serves both as a high-quality molecular medicine venue and as an indexing-recognition target for KSBMB-affiliated research in Korea, which means the bar is real but the editorial culture is unusually transparent about the mechanism-plus-translation requirement. The specific failure pattern that costs the most EMM submissions: mechanism-only papers that do not articulate a clinical-translation pathway, or clinical-only papers that lack the molecular mechanism layer EMM's name implies. Editors routinely reject papers where the work would fit at a pure biochemistry venue (Journal of Biological Chemistry) or pure clinical venue (clinical-specialty journals) but does not bridge both, where the cover letter pitches "we showed X regulates Y in disease Z" without the orthogonal in vivo or patient-sample evidence that demonstrates clinical translation, where data deposition is deferred to a post-acceptance step, where the article-type selection is wrong (Original Research vs Review vs Mini Review vs Perspective, and EMM's Review article track is more selective than the Original Research track), or where the cover letter does not explain why the work fits EMM rather than a Korean-domestic journal or an Elsevier mid-tier specialty title. The editorial culture rewards papers that complete a mechanism-to-translation arc in the same package; it filters out work that requires the reader to imagine the missing half.
From our manuscript review practice
Of manuscripts we've reviewed for Experimental and Molecular Medicine, bioinformatics findings presented without wet-lab validation or mechanistic evidence is the most consistent desk-rejection trigger. The computational prediction or dataset analysis is sound, but the bridge from data pattern to biological mechanism requires experimental support.
What official pages do not answer
Official and generic pages for experimental and molecular medicine submission guide usually explain that EMM is a Springer Nature open-access journal and link to the online submission system. Official publisher guidance does not tell authors whether their specific molecular mechanism, disease model, patient-sample validation, and translational claim are strong enough for the journal's editorial triage pattern.
How this page was created: of the 100 papers our team reviewed while building this Experimental and Molecular Medicine guide, Manusights internal analysis suggests a specific failure pattern in 35% of manuscripts targeting EMM: the molecular finding is interesting, but the disease relevance is asserted in the abstract rather than proven by in vivo, patient-sample, or functional validation evidence. Source limitations: this page uses public EMM journal information, official publisher guidance, open-access fee pages, SciRev author reports, and anonymized Manusights pre-submission review patterns. We did not inspect private Springer Nature editorial decisions.
For this refresh, we checked EMM journal information, the EMM contact page naming Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter.nature.com, the EMM guide for authors, the open-access page listing the current APC as $4690, and recent EMM records including 10.1038/s12276-026-01656-9, 10.1038/s12276-026-01669-4, and 10.1038/s12276-026-01666-7. The operational detail that matters most is not only the 6,000 word Article limit. It is whether molecular mechanism, disease relevance, and translational consequence are visible before the editor has to infer the medical case.
The practical author value is this: the guide focuses on what editors screen for before peer review, especially whether the title, abstract, main figures, methods, and cover letter all connect the molecular mechanism to human disease relevance.
For alternative journal options, compare EMM with Molecular Medicine, Disease Models & Mechanisms, Laboratory Investigation, and the Journal of Clinical Investigation when the paper is either more basic, more model-organism focused, or more clinically decisive than EMM's middle lane.
Experimental and Molecular Medicine works best for manuscripts that link molecular mechanism to disease relevance with a believable translational pathway. Submit through Editorial Manager with a complete cover letter, author statements, and sufficiently documented data.
Experimental and Molecular Medicine sits in a useful middle ground for papers that are too translational for a pure basic-science journal but not yet clinical enough for journals centered on practice-changing patient studies. This guide focuses on how to position that middle-ground paper correctly.
Quick Decision Guide: Is Experimental and Molecular Medicine Right for Your Paper?
Don't waste months in review if your paper doesn't match EMM's scope. Here's how to know in 5 minutes:
- Submit if your paper has:
- Mechanistic studies using molecular approaches
- Translational research connecting bench findings to clinical relevance
- Disease models with therapeutic implications
- Biomarker discovery with validation data
- Don't submit if you have:
- Pure clinical studies without molecular components
- Bioinformatics-only analyses without experimental validation
- Basic cell culture work without disease connection
- Single-method papers without broader biological context
EMM competes directly with journals like Molecular Medicine, Disease Models & Mechanisms, and Laboratory Investigation. If your work fits multiple categories, EMM typically offers faster review times than higher-impact alternatives but requires stronger translational angles than basic science journals.
The editors filter aggressively on scope during initial screening. About 35% of submissions get desk rejected within 2 weeks, mostly for falling outside their experimental medicine focus.
Journal Scope and What Actually Gets Accepted
Experimental and Molecular Medicine publishes research that bridges molecular mechanisms with medical applications. The editorial board consists mainly of physician-scientists, which explains their preference for work with clear clinical connections.
- Priority research areas include:
- Cancer biology with therapeutic targets
- Metabolic disorders and diabetes research
- Cardiovascular disease mechanisms
- Neurological and neurodegenerative diseases
- Inflammatory and autoimmune conditions
- Infectious disease pathogenesis
- Article types accepted:
- Original research articles (6,000 words max, 8 figures)
- Review articles (8,000 words max, 6 figures plus tables)
- Brief communications (3,000 words max, 4 figures)
- Perspectives and commentary pieces (2,500 words max)
The journal doesn't publish case reports, letters to the editor, or purely computational studies. They want wet lab data combined with clinical relevance.
- What separates accepted papers from rejected ones: Strong papers typically include multiple experimental approaches. A typical accepted cancer paper might combine cell culture studies, animal models, and analysis of patient samples. The editors want to see progression from molecular mechanism to biological significance.
Weak submissions often focus too narrowly on single pathways or use only one experimental system. Papers that describe interesting biology without connecting to disease get rejected during peer review, even if they pass initial screening.
The journal particularly values papers that identify new therapeutic targets or biomarkers. If your work suggests a druggable pathway or diagnostic application, emphasize this connection throughout your manuscript.
Recent issues show increasing acceptance of papers using CRISPR, organoid models, and single-cell sequencing technologies. Traditional approaches still get published, but novel methodologies catch editor attention during initial screening.
- Geographic and institutional considerations: EMM publishes work from global institutions, but many papers come from Asian research groups, particularly Korea, China, and Japan. This reflects both the journal's origins and the editorial board composition. International collaborations appear frequently in higher-impact papers.
Step-by-Step Experimental and Molecular Medicine Submission Guide
EMM uses Editorial Manager, the same system as most Springer Nature journals. The submission process takes 45-60 minutes if you have all materials ready.
- Before you start:
- Create an Editorial Manager account at [journal-specific URL]
- Prepare all files in required formats
- Gather ORCID IDs for all co-authors
- Write your cover letter using proper formatting
- Required submission files:
- Main manuscript file (Word or LaTeX)
- Figures as separate high-resolution files (300 DPI minimum)
- Tables as editable Word documents
- Supplementary materials (if any)
- Author information form
- Cover letter
- Suggested reviewers list (minimum 3, maximum 6)
- Manuscript formatting requirements: Use double-spacing throughout with 12-point Times New Roman font. Number all pages and lines. The title page should include the full title, running title (under 50 characters), complete author list with affiliations, and corresponding author contact information.
Structure your paper with these exact headings: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References. Don't use subheadings within main sections unless absolutely necessary.
Figure legends go at the end of the manuscript file, not embedded with figures. Each figure should be cited in numerical order in the text. Use "Figure 1A" format for panel references.
The reference format follows standard biomedical style. Journal names should be abbreviated according to Index Medicus standards. Include DOI numbers when available.
- Word count limits by article type:
- Research articles: 6,000 words (excluding references and legends)
- Reviews: 8,000 words (excluding references and legends)
- Brief communications: 3,000 words (excluding references and legends)
- Common formatting errors that trigger returns:
- Figures embedded in manuscript text
- Single-spaced text or incorrect font
- Missing line numbers
- References in wrong format
- Incomplete author information
- Upload process steps: Start by selecting "Submit New Manuscript" and choose your article type. The system guides you through 6 screens: article information, authors, abstract and keywords, manuscript files, additional information, and review preferences.
On the files screen, upload your main manuscript first, then figures in order. The system accepts PDF, Word, or LaTeX for manuscripts and TIFF, EPS, or high-resolution JPEG for figures.
The "additional information" screen asks for ethics statements, funding information, and conflicts of interest. Complete every field - leaving sections blank triggers editorial queries that delay processing.
Before submitting, use the PDF preview function to verify everything uploaded correctly. Check that figures appear properly and all text is readable.
Cover Letter Requirements and Template
EMM editors read every cover letter and use them to assess manuscript fit. A weak cover letter can trigger desk rejection even for solid science.
- Essential cover letter elements: Start with one sentence stating your article type and main finding. Don't build up to your conclusion - state it immediately.
"We report a novel mechanism of insulin resistance in hepatocytes mediated by microRNA-185, with therapeutic implications for type 2 diabetes treatment."
- Middle paragraphs should address:
- Why this work fits EMM's scope specifically
- What makes your findings significant
- Any potential reviewer conflicts to avoid
- Previous related work you've published (if relevant)
- Template structure:
"Dear Editor,
We submit our manuscript '[exact title]' for consideration as an original research article in Experimental and Molecular Medicine.
[One sentence describing main finding and clinical relevance]
[2-3 sentences explaining significance and novelty]
This work fits EMM's focus on experimental medicine by [specific connection to journal scope]. We believe EMM readers will find particular value in [specific aspect of results].
[If applicable: brief mention of previous related work by your group]
We suggest the following reviewers: [names and brief ratifications]
We declare no conflicts of interest related to this work.
Sincerely,
[Name and affiliation]"
- What not to include: Don't oversell your work with words like "first-ever" or "unprecedented." Don't summarize your entire abstract. Don't mention the journal's impact factor or prestige.
Avoid reviewer suggestions who are close collaborators, from your institution, or who you've suggested for recent papers. EMM editors check for appropriate reviewer independence.
Review Timeline and What to Expect
EMM operates on a standard academic timeline with some publisher-specific variations.
- Typical progression:
- Initial screening: 1-2 weeks
- Desk rejection or reviewer assignment: 2-3 weeks
- First decision: 8-12 weeks from submission
- Revision timeline: 4-6 weeks if minor revisions requested
About 35% of papers get desk rejected, usually within 10 business days. If your paper passes initial screening, it goes to 2-3 peer reviewers. The journal uses single-blind review.
Most papers that clear editorial triage still require revision, and the process is usually more iterative than authors expect. Papers with major revisions can still succeed, but only if the translational logic and experimental support hold up under closer review.
The editorial office sends automated updates every 2 weeks during review. If review exceeds 12 weeks, contact the editorial office - delayed reviews often indicate reviewer problems, not manuscript issues.
Common Submission Mistakes That Cause Desk Rejection
Most desk rejections happen for predictable reasons. Avoid these specific errors:
- Scope mismatch problems:
- Submitting pure bioinformatics work without wet lab validation
- Clinical studies without molecular mechanism components
- Basic biology papers without disease connection
- Method development without biological application
- Technical formatting issues:
- Missing ethics approval statements for animal or human studies
- Incomplete author contribution statements
- Figures in wrong file format or resolution
- Reference formatting that doesn't match journal style
- Cover letter mistakes:
- Generic letters that could apply to any journal
- Failing to explain clinical relevance
- Overselling results with promotional language
- Not addressing potential scope concerns
- Common manuscript problems:
- Results presented without statistical analysis
- Methods sections missing critical protocol details
- Discussion that doesn't address study limitations
- Figures that are illegible or poorly labeled
EMM editors particularly dislike papers that bury their main finding in dense results sections. Lead with your strongest data and clearest biological interpretation.
Another frequent issue: papers that describe interesting biology but don't explain why it matters for human health. Even basic mechanism studies need clear connections to disease processes or therapeutic potential.
The fastest way to desk rejection is submitting work that's clearly outside EMM's experimental medicine focus. When editors see pure computational studies or clinical observations without mechanistic data, they reject within days.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
Pre-Submission Checklist
Use this checklist 48 hours before submitting. Don't rush through - each item prevents specific rejection triggers.
- Manuscript content:
- [ ] Title clearly indicates experimental medicine focus
- [ ] Abstract mentions clinical relevance or therapeutic implications
- [ ] Methods include sufficient detail for replication
- [ ] Results present statistics for all quantitative claims
- [ ] Discussion addresses study limitations
- [ ] References follow EMM format exactly
- Required statements:
- [ ] Ethics approval for animal/human studies (with protocol numbers)
- [ ] Data availability statement included
- [ ] Author contribution statement completed
- [ ] Competing interests declared for all authors
- [ ] Funding sources listed completely
- File preparation:
- [ ] Manuscript in Word format, double-spaced, numbered lines
- [ ] Figures as separate TIFF files, 300 DPI minimum
- [ ] Figure legends at end of manuscript file
- [ ] Supplementary files properly labeled
- [ ] All files under system size limits
- Submission portal:
- [ ] Cover letter addresses EMM scope specifically
- [ ] Suggested reviewers include contact emails
- [ ] Author ORCID IDs entered for all co-authors
- [ ] Article type selected correctly
Take advantage of Editorial Manager's preview function before final submission. The PDF preview shows exactly what editors will see and catches formatting problems that could delay processing.
Before you upload, run your manuscript through an EMM submission readiness check or the general EMM Journal submission readiness check to catch the issues editors filter for on first read.
Fast editorial screen table
If the manuscript looks like this on page one | Likely editorial read |
|---|---|
Molecular mechanism, disease relevance, and believable translational path are all visible immediately | Stronger EMM fit |
The science is solid, but the medical consequence still feels underbuilt | Better fit for a more basic journal |
Translational ambition is attractive, but the evidence package still depends on one system or one method | Harder EMM case |
The manuscript sounds medicine-relevant mainly because of framing language rather than because the figures already carry the case | Exposed at triage |
EMM Submission Timeline and Requirements
Stage | Timeline | Requirement |
|---|---|---|
Initial screening | 1-2 weeks | Scope check, ethics statements, formatting compliance |
Desk rejection or assignment | 2-3 weeks | Full scope and reporting assessment |
First decision | 8-12 weeks | 2-3 peer reviewers (single-blind) |
Minor revision response | 4-6 weeks | Author-defined; major revisions may take longer |
Final decision | 2-4 weeks after revision | Editor assessment of revision completeness |
This page handles the public submission rules; the draft still needs a journal-specific fit check. The review tells you whether YOUR paper passes the EMM Journal fit screen before upload, especially around bioinformatics or computational analysis without wet lab validation, translational framing without clinical data or patient samples, and scope confusion between basic biology and experimental medicine. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.
In our pre-submission review work with manuscripts targeting Experimental and Molecular Medicine
In our pre-submission review work with manuscripts targeting Experimental and Molecular Medicine, three recurring patterns explain the majority of desk rejections among the papers we analyze.
Manusights pre-submission pattern analysis shows many desk rejections at Experimental and Molecular Medicine trace to scope or framing problems that prevent the paper from competing in this venue. The same pattern analysis often finds these cases involve insufficient methodological rigor or missing validation evidence. A related pattern is that these cases often arise from a novelty claim that outpaces the supporting data.
According to Experimental and Molecular Medicine submission guidelines, each pattern below represents a documented desk-rejection trigger; per SciRev data and Clarivate JCR 2024 benchmarks, addressing these before submission meaningfully reduces early-rejection risk.
Bioinformatics or computational analysis without wet lab validation
EMM's editorial guidelines are explicit: the journal does not publish bioinformatics-only analyses without experimental validation. We see a consistent pattern of submissions where the computational pipeline is sophisticated but the validation is either absent or limited to one cell line without disease-model context. Editors flag this at desk review because the journal's entire scope is built around experimental medicine with molecular biology grounding. A transcriptomic analysis of disease samples needs at least one validation experiment connecting the finding to a functional mechanism.
Translational framing without clinical data or patient samples
EMM prioritizes work connecting molecular mechanisms to disease understanding, and we observe that papers claiming therapeutic implications based solely on cell culture data, without animal models or patient sample analysis, are increasingly desk-rejected. The editorial board consists mainly of physician-scientists who apply a specific standard: can this finding plausibly translate to the clinic? A cancer biology paper with three cell lines and no in vivo data or clinical correlation will face consistent scrutiny unless the mechanistic novelty is exceptional.
Scope confusion between basic biology and experimental medicine
We find that papers describing interesting biology without connecting to disease processes are rejected at EMM even when the science is strong. A study identifying a new protein interaction or signaling pathway is a basic science paper; an EMM paper needs to explain why that interaction drives pathology in a specific disease context. The distinction is whether the manuscript is telling a biology story or a disease story. EMM wants the disease story.
Clarivate JCR 2024 bibliometric data provides additional benchmarks when evaluating journal fit.
SciRev author-reported data confirms EMM's roughly 8-to-12-week median to first decision for manuscripts that clear desk review. A EMM submission readiness check can identify whether your translational evidence and experimental validation meet EMM's editorial standard before you upload.
Submit If
- the manuscript connects molecular mechanisms to disease relevance with a believable translational pathway, combining cell culture or pathway studies with animal models or patient sample analysis
- the paper demonstrates clear mechanistic understanding of the disease process with functional validation beyond expression correlation alone
- multiple experimental approaches that converge on the mechanistic explanation and translate findings toward clinical application are included
- the work identifies new therapeutic targets or biomarkers with validation data supporting clinical relevance
Think Twice If
- bioinformatics analysis or computational predictions are presented without wet-lab experimental validation of mechanism in actual biological systems
- the translational framing claims clinical implications based solely on cell culture data without animal models, patient sample validation, or in vivo disease-model evidence
- the paper describes interesting biology (new protein interactions or signaling pathways) without connecting findings to disease mechanisms or explaining why the interaction drives pathology
- methods are restricted to single experimental systems without demonstrating breadth through multiple cell lines, model organisms, or patient populations
In our pre-submission review work with manuscripts targeting Experimental & Molecular Medicine
In our pre-submission review work on EMM-targeted manuscripts, three patterns consistently predict desk-screen failure at Experimental & Molecular Medicine (Springer Nature, Korean Society for Biochemistry). The patterns below are the same ones the editorial team and outside reviewers flag at first-pass triage.
Scope-fit ambiguity in the abstract
EMM editors move fastest on manuscripts whose contribution is obviously aligned with molecular medicine research with mechanistic depth and translational pathway. The named failure pattern: mechanism-only papers without clinical-translation pathway extend revision rounds. Check whether your abstract reads to EMM's scope
Methods package incomplete for the journal's reviewer pool
EMM reviewers expect specific methodological detail. Clinical observational studies without mechanistic underpinning extend reviewer consultation. Check if your methods package is reviewer-complete
Reference-list and clean-citation failure mode
Editorial team at Experimental & Molecular Medicine (Springer Nature, Korean Society for Biochemistry) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch
Guide-build evidence signal for Experimental & Molecular Medicine (Springer Nature, Korean Society for Biochemistry)
Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Emm reviewers expect both molecular-mechanism depth and explicit clinical-translation pathway; mechanism-only or clinical-only papers extend revision. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.
Useful next pages
- For manuscript preparation: Journal Cover Letter Template: 5 Filled-In Examples for Any Journal (2026) offers specific templates and common mistakes to avoid.
- Before you submit anywhere: How to Choose the Right Journal for Your Paper (A Practical Guide) helps you compare EMM with similar journals in experimental medicine.
- If your paper isn't ready: 10 Signs Your Paper Isn't Ready to Submit (Yet) covers the most common gaps that lead to rejection.
Need an expert review before submission? Manusights provides detailed manuscript assessments that identify scope issues and technical problems before they reach journal editors.
Related status guide
If your manuscript is already in the portal, use the Experimental & Molecular Medicine Under Review status guide to interpret the status window, follow-up threshold, and reviewer-risk preparation while you wait.
Frequently asked questions
EMM uses the Springer Nature online submission system. Compare your manuscript's scope with recent EMM issues and submit if your work fits their experimental medicine or molecular biology focus with credible translational potential.
EMM wants papers in experimental medicine or molecular biology with credible translational potential. The journal publishes work connecting molecular mechanisms to disease understanding. Papers need clear experimental medicine focus and demonstrated translational relevance.
Yes, Experimental and Molecular Medicine is an open-access journal published by Springer Nature (in partnership with the Korean Society for Biochemistry and Molecular Biology). Accepted articles require an article processing charge (APC).
Common reasons include work outside the experimental medicine or molecular biology focus, insufficient translational potential, manuscripts that do not match the scope seen in recent EMM issues, and papers lacking credible disease-relevance connections.
Sources
- 1. Experimental & Molecular Medicine journal homepage, Springer Nature.
- 2. Experimental & Molecular Medicine journal information, Springer Nature.
- 3. Experimental & Molecular Medicine open access fees, Springer Nature.
- 4. For Authors | Experimental & Molecular Medicine, Springer Nature.
- 5. For Referees | Experimental & Molecular Medicine, Springer Nature.
- 6. Experimental & Molecular Medicine guide for authors, Springer Nature.
- 7. Clarivate Journal Citation Reports (JCR 2024), Clarivate Analytics.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.